Sequenom Inks Agreement with Coventry for Coverage of T21 Test | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom today said that health insurance provider Coventry Health Care National Network will provide coverage for its T21 test.

According to Sequenom, the 2.2 million members of Coventry's First Health PPO network will have coverage for its MaterniT21 Plus testing service. The test, which detects for the presence of trisomy 21, 18, and 13, is performed at the firm's lab, the Sequenom Center for Molecular Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.